aiwiki.page
English
Health / Medicine & Treatment / end-of-life-care

End-of-Life Care

End-of-life care addresses physical, psychological, social, and spiritual needs as death approaches, while aligning treatment with the person’s values and goals.

42 keywords5 linked from8 not yet writtenWritten by AI
Quality of LifePalliative CareHospice CareEthicsWorld Health Org…United StatesPrimary CareCancerEnd-of-Lif…

End-of-life care is the care of people approaching death from advanced illness, progressive frailty, or an acute condition from which recovery is no longer expected. It includes relief of suffering, communication about prognosis and treatment, support for decision-making, practical assistance, and care for families and other close persons. Its central concerns are the person’s comfort, dignity, relationships, and quality of life, together with the appropriateness of medical interventions.

There is no universally accepted time boundary for the end of life. Some services use the term for the final days or weeks; others include months or approximately the last year of life. End-of-life care overlaps with palliative care, which can begin much earlier in serious illness, and with hospice care, a service model whose organization and eligibility rules vary between countries. It is not defined simply by stopping disease-directed treatment: symptom relief, treatment of reversible problems, and selected life-prolonging interventions may occur together.

The field brings clinical practice into close contact with ethics, law, family life, and cultural understandings of death. Its quality depends not only on professional expertise but also on access to medicines, continuity between services, recognition of uncertainty, and respect for individual preferences.

Scope and historical development

Care for dying people long preceded modern hospitals. Families, religious communities, charitable institutions, and local practitioners provided shelter, nursing, and companionship, although their resources and purposes differed considerably. Modern end-of-life care emerged partly in response to changes in the place and circumstances of death. During the twentieth century, expanding hospital systems, antibiotics, intensive care, and technologies for sustaining organ function made it possible to postpone death in situations that previously offered few treatment options. These developments also created difficult questions about when intervention remained beneficial.

A major influence was the modern hospice movement. Cicely Saunders, who had trained in nursing, social work, and medicine, founded St Christopher’s Hospice in London in 1967. Its combination of clinical care, teaching, and research helped establish hospice as more than a place of custodial care. Saunders’s concept of “total pain” described suffering as an interaction of physical symptoms, emotional distress, social circumstances, and spiritual or existential concerns. This approach informed multidisciplinary services in many countries.

The development of specialist palliative medicine extended these principles beyond dedicated hospices. Hospital consultation teams, outpatient clinics, community services, and home-care programs increasingly addressed serious illness before the final phase. The World Health Organization defines palliative care in relation to preventing and relieving suffering associated with life-threatening illness, rather than by a fixed prognosis. End-of-life care is therefore best understood as a phase and set of responsibilities within a broader continuum, not as a synonym for every form of palliative care.

The boundaries between hospice and end-of-life care remain jurisdiction-specific. In the United States, the Medicare hospice benefit generally uses a prognosis of six months or less if an illness follows its usual course, together with certification and election requirements. This is an eligibility rule, not a biological prediction that every enrolled person will die within six months. Other countries organize hospice provision through different combinations of public funding, charitable support, inpatient facilities, and community teams.

Contemporary practice also distinguishes a general palliative approach from specialist care. General clinicians and nurses commonly provide basic symptom assessment, conversations about goals, and family support. Specialist teams address particularly complex symptoms, difficult decisions, or severe psychosocial distress. End-of-life responsibilities consequently extend across primary care, hospitals, residential facilities, emergency services, and community organizations rather than belonging to one specialty or building.

Recognizing approaching death and different illness trajectories

Recognition that a person may be approaching death is a clinical judgment made under uncertainty. It draws on the underlying illness, response to treatment, functional ability, nutritional state, symptom burden, and recent pattern of deterioration. No single laboratory result or prognostic score reliably establishes an individual’s remaining lifespan across all conditions. Prognostic estimates describe probabilities in groups and require interpretation in the circumstances of a particular person.

Different diseases produce different patterns of decline. Some advanced cancers have a period of relatively preserved function followed by more rapid deterioration, although modern treatments can substantially alter this course. Heart failure and chronic obstructive pulmonary disease often involve repeated exacerbations, partial recovery, and continuing risk of sudden death. People may survive several episodes that initially appear terminal, making it difficult to identify a single transition into end-of-life care.

Advanced dementia and frailty commonly involve prolonged dependency, impaired mobility, swallowing difficulties, infections, and reduced ability to communicate. In these conditions, the approach of death may be less clearly marked by a discrete event. Severe stroke, trauma, or overwhelming sepsis can instead produce an abrupt crisis in which decisions about life support occur before the person or family has had time to prepare. These trajectories explain why needs-based assessment is often more useful than a rigid time threshold.

Assessment tools can organize observation without eliminating uncertainty. The Palliative Performance Scale describes domains such as ambulation, activity, self-care, intake, and consciousness. Disease-specific models may incorporate functional status, laboratory findings, or symptoms. Their accuracy depends on the population and setting in which they were developed. A model validated in advanced cancer cannot automatically be applied to severe neurological disease or a heterogeneous nursing-home population.

In children, life-limiting conditions may be congenital, metabolic, neurological, or malignant, and some have courses extending over many years. Planning therefore often occurs alongside developmentally appropriate education, family life, and active treatment. In older adults, several illnesses may contribute simultaneously, making a single diagnostic label an incomplete account of decline.

Recognizing possible dying does not establish that every new symptom is irreversible. Medication toxicity, urinary retention, infection, or metabolic disturbance can resemble terminal deterioration. Clinical practice therefore distinguishes the question of whether a problem is potentially reversible from the separate question of whether investigating or treating it fits the person’s goals. Prognosis is usually communicated as an estimate that can be revised, rather than as an exact date.

Relief of physical symptoms

Physical symptom care begins with assessment of the symptom’s severity, likely mechanism, effect on daily life, and meaning to the person. A symptom can have several simultaneous causes: breathlessness may reflect fluid accumulation, lung disease, muscle weakness, and fear, while pain may combine tissue injury and nerve damage. Self-report is preferred when possible. For people who cannot communicate verbally, clinicians use observation, information from familiar caregivers, and validated behavioral measures, while recognizing that behavior is not a precise substitute for reported experience.

Pain is common but not universal near death. Treatment depends on whether pain is predominantly inflammatory, visceral, neuropathic, or related to movement and positioning. Opioids, including morphine, have an established role in moderate to severe pain, alongside nonopioid medicines, selected procedures, and physical measures. Their use requires attention to adverse effects, previous exposure, organ function, and interactions. Reduced kidney function can cause accumulation of some drugs or active metabolites. Appropriate symptom treatment is distinct from administering medication with the intention of causing death.

Breathlessness is a subjective sensation whose severity may not closely match oxygen saturation or imaging findings. Depending on the clinical situation, management may include treatment of contributing disease, positioning, airflow across the face, psychological support, and medication. Oxygen is not uniformly effective in people without low blood oxygen. Opioids may relieve refractory breathlessness in selected circumstances, but their benefits and risks vary with disease, setting, and treatment goals; sedation and respiratory effects remain relevant to monitoring.

Other symptoms frequently interact. Nausea can arise from medication, impaired gastric emptying, biochemical disturbance, or bowel obstruction, and treatment is directed toward the likely mechanism. Constipation may reflect immobility, low intake, and opioid effects. Fatigue can be associated with progressive disease, anemia, sleep disruption, mood symptoms, or treatment burden. Skin care, mouth care, pressure relief, bladder management, and comfortable positioning are important forms of symptom care even when no complex procedure is involved.

Delirium is an acute disturbance of attention and awareness that can fluctuate over hours. Near the end of life it may result from infection, organ failure, medication effects, dehydration, or several factors together. It differs from dementia, although the two can coexist. Assessment considers potentially reversible contributors and the burden of investigation. Familiar surroundings, reduced unnecessary stimulation, and support for communication are common components of care. Medication is not automatically beneficial for every episode of confusion; its role depends on distress, agitation, safety, and the clinical context.

Symptom control is an ongoing process rather than a single prescription. Changes in swallowing, consciousness, circulation, and organ function can alter both symptoms and drug effects. Reassessment also distinguishes symptom relief from unwanted loss of alertness, since people differ in how they value comfort, wakefulness, and the ability to interact.

Communication, capacity, and advance care planning

Communication about dying concerns more than disclosure of a prognosis. It includes establishing what the person understands, how much information they want, who should participate, and which outcomes matter most. Some people prioritize time at home, others maintaining alertness, attending a family event, or pursuing any intervention offering a meaningful chance of recovery. These priorities can change as illness progresses. Shared decision-making relates clinical options and their likely consequences to the person’s values without assuming that everyone prefers the same degree of involvement.

Advance care planning is a process of discussing and recording preferences for future care, particularly for circumstances in which a person may be unable to decide or communicate. It may include appointing a surrogate decision-maker, discussing acceptable and unacceptable outcomes, and completing legally recognized documents. It is broader than signing a form. Its usefulness depends on whether information is available when needed, understood by those involved, and updated when circumstances or preferences change.

An advance directive can state treatment preferences, designate a representative, or do both, depending on local law. Some jurisdictions also use portable medical orders for people with serious illness or frailty. Such orders translate current treatment decisions into instructions usable across care settings; they do not serve exactly the same purpose as a general statement of future wishes. The legal status, terminology, witnessing requirements, and interpretation of these documents differ between jurisdictions.

Decision-making capacity is generally assessed in relation to a particular decision at a particular time. It commonly involves the ability to understand relevant information, appreciate its significance, consider the options, and communicate a choice. A diagnosis of dementia or mental illness does not by itself establish incapacity. Conversely, a person who appears socially fluent may be unable to understand a complex treatment decision. Delirium, medication effects, pain, language barriers, and hearing impairment can affect participation and require careful distinction.

When a person lacks capacity, the authority and responsibilities of a surrogate depend on applicable law. Common standards include following known wishes, using substituted judgment about what the person would choose, and considering best interests when preferences are unknown. Family agreement can be valuable, but relatives do not necessarily have identical views or automatic legal authority merely by being present.

Structured family meetings can clarify prognosis, identify misunderstandings, and separate disagreements about facts from disagreements about values. Professional interpreters are important where language differences could compromise understanding. Documentation records not only decisions but their reasoning, uncertainties, participants, and conditions for review. Communication remains a continuing clinical task, especially after deterioration, transfer between services, or a major change in treatment.

Life-sustaining treatment and ethical boundaries

End-of-life decisions often concern interventions that can sustain biological function without reversing the underlying illness. Examples include mechanical ventilation, dialysis, vasopressor treatment, artificial nutrition, and cardiopulmonary resuscitation. Their appropriateness depends on the clinical objective, probability of achieving it, burdens, and the person’s preferences. The same intervention can be restorative in one situation and burdensome with little prospect of benefit in another.

A decision not to attempt resuscitation applies to treatment after cardiac or respiratory arrest; it does not by itself mean that all other care stops. Antibiotics, oxygen, transfusion, surgery, or intensive symptom treatment may still be consistent with the person’s goals. Similarly, a decision against intubation is not necessarily a refusal of every form of respiratory support. Clear specification matters because broad labels such as “comfort care” can conceal different understandings among clinicians and families.

A time-limited trial of treatment is sometimes used when outcomes are uncertain. The intervention is undertaken with an agreed purpose, a period for reassessment, and indicators of improvement or deterioration. For example, intensive treatment may be evaluated against recovery of organ function or the ability to leave intensive care. Such a trial is not simply indefinite treatment with a nominal review date: its meaning depends on shared understanding of what will happen if the intended outcome is not achieved.

Many professional ethical frameworks regard withholding and withdrawing treatment as subject to the same basic considerations of consent, benefit, and burden, although legal procedures and social attitudes vary. Stopping ventilation or dialysis can be emotionally different from not starting it, even where the ethical justification is similar. Withdrawal requires continued care for breathlessness, anxiety, pain, and family distress; it is not withdrawal of attention or responsibility.

Palliative sedation is the monitored use of medication to reduce consciousness for relief of otherwise refractory suffering. “Refractory” refers to symptoms that cannot be adequately relieved by other acceptable measures within the available circumstances. Sedation varies in depth and duration. It requires a clear indication, proportionate use, discussion and consent where possible, and review. It is distinct in purpose and practice from deliberately causing death.

Euthanasia and assisted dying are separate legal and ethical categories, with definitions and permitted practices that differ substantially between jurisdictions. Ordinary relief of symptoms, respect for a valid refusal of treatment, and decisions not to continue ineffective or disproportionately burdensome intervention should not be conflated with them. In particular, an intention to relieve distress is not equivalent to an intention to cause death, even when treatment occurs in a person who is already dying.

Care during the final days and hours

The final phase of dying often involves increasing sleepiness, profound weakness, reduced oral intake, difficulty swallowing, and changes in breathing and circulation. Urine output may fall, hands and feet may become cool, and skin color may become mottled. Breathing can become irregular, with pauses. These findings vary between individuals and do not provide a precise countdown. Some people die without displaying every commonly described sign.

Reduced eating and drinking are frequent consequences of the dying process. They can reflect altered metabolism, diminished appetite, weakness, and impaired swallowing rather than a simple lack of offered food. Assistance with oral intake, when possible and desired, is different from clinically assisted nutrition delivered through a tube or vein. Mouth care can address dryness even when substantial fluid intake is no longer feasible. Artificial hydration may have benefits in selected circumstances, but it can also contribute to fluid overload or secretions; evidence does not establish a uniform benefit for all dying patients.

Noisy respiratory secretions may occur when a person can no longer clear saliva and airway fluid. The sound can be distressing to those present, but it does not reliably indicate that the unconscious person is experiencing suffocation. Position changes and selected medicines are used in some settings, although evidence for the effectiveness of particular treatments is limited. Explaining the possible meaning of these sounds is part of care for families as well as clinical management.

Practical care changes when swallowing or self-report becomes difficult. Medication routes may change, and treatments without an achievable near-term purpose may be reviewed. Monitoring is selected for whether it contributes to comfort or decisions, rather than performed automatically. Repeated blood sampling, transfers, alarms, and routine observations can impose burdens without changing care in an expected death. Conversely, symptom assessment, nursing presence, and timely access to needed medicines remain important.

The environment can affect the experience of dying. Privacy, access for chosen companions, opportunities for religious observance, and avoidance of unnecessary disruption may matter greatly. Some people want continuous company, while others prefer fewer visitors or periods of quiet. Consciousness may fluctuate, and communication can become nonverbal. Explanations to those present generally distinguish observable changes from assumptions about what the person is experiencing.

After death, professionals verify or pronounce death according to local rules and arrange subsequent certification. Brain death is a distinct determination based on defined neurological criteria and should not be confused with ordinary bedside recognition of death following cessation of circulation. Procedures involving a death certificate, possible coroner or medical-examiner referral, handling of implanted devices, and care of the body depend on jurisdiction and circumstances. Religious and cultural practices are accommodated within those requirements.

Psychological, social, spiritual, and bereavement care

Approaching death can affect identity, independence, relationships, and a person’s sense of meaning. Emotional responses include sadness, fear, anger, relief, uncertainty, and periods of ordinary enjoyment. These experiences do not necessarily follow a fixed sequence. The widely circulated idea that every dying or bereaved person passes through predictable stages is not an adequate description of individual experience. Responses vary with illness, biography, social support, beliefs, and material circumstances.

Psychological assessment distinguishes understandable distress from conditions such as major depression, severe anxiety, or delirium. Physical symptoms and mental distress can reinforce each other: uncontrolled breathlessness may increase fear, and fear may heighten the experience of breathlessness. Support can involve listening, clear information, maintaining meaningful activities, and specialist psychological or psychiatric input when indicated. The limited time available, treatment burden, and altered organ function affect the relevance of particular interventions.

Social concerns are often concrete. A person may be worried about income loss, housing, immigration status, dependent children, a family business, or who will care for a partner after death. Family caregivers may undertake complex work involving medicines, mobility, personal care, and nighttime supervision. Their ability to provide care depends on health, employment, finances, housing, and the availability of paid support. Describing home care as a preference does not establish that a household has the resources to deliver it.

Spiritual care addresses meaning, hope, reconciliation, guilt, connection, and beliefs about death. It may involve a religious representative, a trained spiritual-care professional, or conversations unrelated to organized religion. Practices associated with religion can influence dietary rules, prayer, modesty, the handling of the body, and who should be present. Individual preferences cannot reliably be inferred from membership in a cultural or religious group. Some people welcome explicit discussion of death; others prefer information to be shared through family members.

Bereavement support can begin before death through preparation, explanation of likely changes, and recognition of anticipatory grief. After death, support may include information, practical assistance, follow-up contact, community resources, and targeted mental-health care. Grief is highly variable and should not automatically be treated as illness. Prolonged grief disorder describes a persistent, impairing pattern beyond culturally expected grieving, using criteria that differ between diagnostic systems.

Children and adolescents affected by a family member’s dying have needs shaped by development, attachment, and their understanding of illness and death. Families can also experience conflict, estrangement, or differing interpretations of responsibility. End-of-life services therefore consider who matters to the person rather than assuming that legally recognized relatives are the only significant relationships. Support extends to partners, friends, and other chosen companions while respecting confidentiality and legal decision-making arrangements.

Organization of services and unequal access

End-of-life care is delivered in homes, hospitals, care homes, hospices, and other community settings. No setting is inherently best for every person. Home may offer familiarity but require substantial caregiver capacity; hospital may provide rapid access to treatment but involve transfers, noise, and unfamiliar staff. A person’s preferred location can change as symptoms or family circumstances change. Place of death is therefore an incomplete measure of whether care respected the person’s priorities.

Multidisciplinary teams commonly include physicians, nurses, social workers, pharmacists, spiritual-care practitioners, and rehabilitation professionals. Their responsibilities overlap but are not interchangeable. Nursing continuity often makes changes in symptoms or caregiver strain visible. Pharmacy input can address interactions, formulations, and medicine availability. Social work can connect clinical planning with benefits, housing, safeguarding, and practical support. Specialist teams frequently advise rather than replace the clinicians already responsible for the person.

Transitions between settings are vulnerable points. A hospital discharge can fail if medicines are unavailable, equipment has not arrived, a family does not understand the plan, or urgent help cannot be obtained overnight. Shared records, clear responsibility, anticipatory arrangements, and reliable out-of-hours services support continuity. Digital communication can improve access for some households, but connectivity, disability, language, and data privacy affect its usefulness.

Access is shaped by health financing, workforce distribution, and medicine regulation. Controlled medicines require safeguards against diversion and unsafe use, yet excessive regulatory barriers can also obstruct legitimate pain treatment. The WHO includes palliative care within the responsibilities of health systems, and the 2014 World Health Assembly resolution WHA67.19 called for strengthening it as a component of comprehensive care. Integrating such services with universal health coverage involves both clinical provision and protection from financial hardship.

Unequal access can arise from geography, poverty, disability, language, discrimination, and diagnosis. Historically, services developed strongly around cancer, while people with organ failure, dementia, or complex multimorbidity have often faced less predictable referral pathways. Rural and remote populations may have fewer specialist teams and longer travel distances. People without stable housing may lack a safe place for home care, secure medicine storage, or a consistent caregiver.

A public-health perspective also considers community networks, caregiver support, education, and the distribution of unmet need. The COVID-19 pandemic exposed vulnerabilities in care homes and community services, while infection-control restrictions altered visiting and bedside support. These experiences demonstrated that end-of-life care depends on the wider health system, including staffing, supply chains, emergency planning, and the ability to preserve communication during crises.

Evidence, quality measurement, and unresolved questions

Research in end-of-life care studies symptoms, communication, service models, caregiver outcomes, and the effects of treatment decisions. Trials of early palliative care in selected populations have found improvements in some patient-centered outcomes. A widely cited 2010 trial led by Jennifer Temel in metastatic non-small-cell lung cancer reported better quality of life and mood with early integrated palliative care, along with differences in end-of-life treatment and survival. Such results concern a defined intervention and population; they do not establish that every palliative service improves survival or that specialist involvement has identical effects across diseases.

A randomized controlled trial can provide strong evidence about an intervention, but this field presents practical challenges. Rapid deterioration can make recruitment difficult, participants may lose the ability to complete assessments, and death can interrupt follow-up. Excluding people with cognitive impairment or language barriers may make study populations unrepresentative. Family-proxy reports can add important information but may differ from the patient’s own experience.

Interpretation also depends on the outcome measured. Symptom intensity, quality of life, caregiver distress, hospital admission, and cost describe different dimensions of care. A lower hospitalization rate may reflect better community support, but it can also reflect barriers to needed treatment. Reduced expenditure is not, by itself, evidence of better care. Similarly, greater use of hospice does not prove that preferences were understood or that symptoms were controlled.

Patient-reported outcomes give direct information about symptoms and concerns when people can report them. Other measures include timely access to services, documented communication, availability of medicines, avoidable disruptions, and family-reported experiences after death. Preference-concordant care is an important goal but difficult to measure: preferences can change, records can be incomplete, and an outcome may become impossible because of clinical or practical constraints.

There is continuing uncertainty about the best organization and timing of services for noncancer illnesses, the benefits of some treatments in the final days, and which forms of caregiver support are most effective in different settings. Evidence for artificial hydration near death, management of terminal secretions, and some uses of medication remains limited or context-dependent. These gaps make it important to distinguish established practice, plausible mechanisms, and demonstrated benefit.

Research ethics requires particular attention to consent, vulnerability, participant burden, and the interests of people unable to communicate. Protection does not necessarily mean excluding dying people from research, since exclusion can perpetuate weak evidence for their care. Appropriate study designs balance scientific value with comfort, feasible participation, and respect for changing capacity. Quality improvement similarly examines not only whether a document or referral exists, but whether care remains responsive to the person’s symptoms, circumstances, and expressed goals.